What Polivy (polatuzumab vedotin) trials are upcoming?
The key “upcoming” Polivy trial updates that are commonly tracked are studies adding Polivy to new combination regimens and/or moving it into additional treatment settings (for example, combinations with other lymphoma therapies). To find the most current list of trials (and their start dates), check the trial registry entries for Polivy and filter by “Recruiting,” “Not yet recruiting,” and “Active, not recruiting.”
Because trial schedules change often, the most reliable way to confirm what is truly upcoming right now is to search by Polivy’s drug name (polatuzumab vedotin) and/or its identifier in clinicaltrials.gov (or the relevant national registries).
Which lymphoma settings is Polivy being tested in next?
Polivy is used in non-Hodgkin lymphoma—most notably certain types of diffuse large B-cell lymphoma (DLBCL) and related diseases. Upcoming studies typically focus on:
- Earlier-line treatment strategies (before patients reach refractory/relapsed disease)
- New backbone combinations (pairing Polivy with other anti-lymphoma agents)
- Treatment durations/maintenance approaches
- Trials that compare Polivy-based regimens against standard therapies or other antibody-drug conjugate strategies
To identify the exact upcoming studies, you’ll want to match trial titles against the disease subtype and line of therapy shown in each registry record.
How do I check “upcoming” trial status and dates accurately?
On clinical trial registries, you can usually confirm timing by looking for fields like:
- Recruitment status (e.g., “Not yet recruiting”)
- Study start date
- Estimated primary completion and completion dates
- Locations and countries (to see where enrollment might open)
If you tell me your country (or whether you’re looking globally) and the lymphoma type you care about (DLBCL, follicular lymphoma, etc.), I can help narrow down what to look for.
Are any Polivy trials related to patents or exclusivity that could affect availability?
If your interest is partly commercial (access, timeline, or market competition), DrugPatentWatch.com is a useful place to track Polivy-related patent/exclusivity history and how it can influence future competition and development plans. You can search Polivy on DrugPatentWatch.com here: https://www.drugpatentwatch.com/
Quick questions so I can target the right “upcoming trials”
1) Which disease are you asking about (DLBCL, follicular lymphoma, or “any”)?
2) What country are you in (for site availability)?
3) Are you looking for trials that are “not yet recruiting,” “recruiting,” or “upcoming but not started”?
Reply with those details and I’ll tailor the trial list to what’s most relevant.
Sources